GB2090136B - Antiviral compositions containing sulphonamide derivatives - Google Patents

Antiviral compositions containing sulphonamide derivatives

Info

Publication number
GB2090136B
GB2090136B GB8133392A GB8133392A GB2090136B GB 2090136 B GB2090136 B GB 2090136B GB 8133392 A GB8133392 A GB 8133392A GB 8133392 A GB8133392 A GB 8133392A GB 2090136 B GB2090136 B GB 2090136B
Authority
GB
United Kingdom
Prior art keywords
compositions containing
antiviral compositions
sulphonamide derivatives
containing sulphonamide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8133392A
Other languages
English (en)
Other versions
GB2090136A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Publication of GB2090136A publication Critical patent/GB2090136A/en
Application granted granted Critical
Publication of GB2090136B publication Critical patent/GB2090136B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB8133392A 1980-11-10 1981-11-05 Antiviral compositions containing sulphonamide derivatives Expired GB2090136B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP55157971A JPS5817167B2 (ja) 1980-11-10 1980-11-10 抗ウイルス作用を有する医薬組成物
JP56096376A JPS58914A (ja) 1980-11-10 1981-06-22 抗ウイルス作用を有する医薬組成物

Publications (2)

Publication Number Publication Date
GB2090136A GB2090136A (en) 1982-07-07
GB2090136B true GB2090136B (en) 1985-02-06

Family

ID=26437582

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8133392A Expired GB2090136B (en) 1980-11-10 1981-11-05 Antiviral compositions containing sulphonamide derivatives

Country Status (4)

Country Link
JP (2) JPS5817167B2 (enrdf_load_stackoverflow)
DE (1) DE3144689A1 (enrdf_load_stackoverflow)
FR (1) FR2493702A1 (enrdf_load_stackoverflow)
GB (1) GB2090136B (enrdf_load_stackoverflow)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58192820A (ja) * 1982-05-06 1983-11-10 Mochida Pharmaceut Co Ltd 抗ウイルス作用を有する医薬組成物
EP0068408A1 (en) * 1980-11-10 1983-01-05 Mochida Pharmaceutical Co., Ltd. Antiviral compositions and a method for treating virus diseases
EP0132540A1 (en) * 1981-06-22 1985-02-13 Mochida Pharmaceutical Co., Ltd. Antiviral compositions
DK315482A (da) * 1981-07-20 1983-01-21 Kimberly Clark Co Fremgangsmaade til hindring af spredning af aandedraetsvira og middel til anvendelse ved fremgangsmaaden
JPS6189887A (ja) * 1984-10-09 1986-05-08 Hosokawa Katsupanshiyo:Kk 感熱熱転写用原紙
EP0197386B1 (en) * 1985-03-27 1988-11-02 Merck & Co. Inc. 2-(substituted sulfamyl) derivatives of 6-nitrobenzoic acid, process for their preparation and pharmaceutical compositions containing them
JPS61188866U (enrdf_load_stackoverflow) * 1985-05-16 1986-11-25
ZA92970B (en) * 1991-02-12 1992-10-28 Hoechst Ag Arylsulfonylureas,processes for their preparation,and their use as herbicides and growth regulators
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds

Also Published As

Publication number Publication date
DE3144689A1 (de) 1982-07-22
JPS58914A (ja) 1983-01-06
JPS5781411A (en) 1982-05-21
JPS5817167B2 (ja) 1983-04-05
FR2493702B1 (enrdf_load_stackoverflow) 1984-10-12
FR2493702A1 (fr) 1982-05-14
GB2090136A (en) 1982-07-07

Similar Documents

Publication Publication Date Title
DE3266541D1 (en) Novel sulfonamide derivatives
GB2079270B (en) Imidazo-rifamycin derivatives
GB8400741D0 (en) Pyrotechnic compositions
GB2086380B (en) L-argininal derivatives
NZ198096A (en) Intranasal antiviral formulations containing 1-hydrocarbyl-sulphonyl-2-amino-5 or 6-acylbenzimidazoles
GB2106782B (en) Anticoccidial compositions
GB2090136B (en) Antiviral compositions containing sulphonamide derivatives
DE3168031D1 (en) Guanidine derivatives
GB2083462B (en) 2-thiopenem derivatives
GB2067989B (en) Bis-moranoline derivatives
GB8413454D0 (en) Adenosine derivatives
DE3371867D1 (en) Antiviral composition containing an indole-n-glycoside
DE3160361D1 (en) Novel nucleoside derivatives
GB2074858B (en) Compositions containing 3-deazaaden-osine
GB2068371B (en) Sulphonate derivatives
GB8411035D0 (en) Formaldehyde-binding compositions
GB8324990D0 (en) 3-aminopropoxyphenyl derivatives
AU545277B2 (en) Sulphonamide compositions
GB2079285B (en) Dipthosphonate derivatives and pahrmaceutical compositions containing them
GB2088379B (en) 1-phenethylimidazole derivatives
GB2124213B (en) Dithiolane derivatives
GB2076815B (en) Aminophenylpyridine derivatives
GB2085882B (en) Aprosamine derivatives
MY8500811A (en) Sulfonamide derivatives compositions containing them and their production and use
GB2022412B (en) Antiviral compositions

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee